BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 18767178)

  • 1. Accuracy of 18F-FDG-PET/CT for staging of oral squamous cell carcinoma.
    Pentenero M; Cistaro A; Brusa M; Ferraris MM; Pezzuto C; Carnino R; Colombini E; Valentini MC; Giovanella L; Spriano G; Gandolfo S
    Head Neck; 2008 Nov; 30(11):1488-96. PubMed ID: 18767178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective study of [18F]fluorodeoxyglucose positron emission tomography and computed tomography and magnetic resonance imaging in oral cavity squamous cell carcinoma with palpably negative neck.
    Ng SH; Yen TC; Chang JT; Chan SC; Ko SF; Wang HM; Lee LY; Kang CJ; Wong AM; Liao CT
    J Clin Oncol; 2006 Sep; 24(27):4371-6. PubMed ID: 16983105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utility of 2-[18F] fluoro-2-deoxy-D-glucose positron emission tomography and positron emission tomography/computed tomography imaging in the preoperative staging of head and neck squamous cell carcinoma.
    Roh JL; Yeo NK; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
    Oral Oncol; 2007 Oct; 43(9):887-93. PubMed ID: 17207656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Staging of the neck in patients with oral cavity squamous cell carcinomas: a prospective comparison of PET, ultrasound, CT and MRI.
    Stuckensen T; Kovács AF; Adams S; Baum RP
    J Craniomaxillofac Surg; 2000 Dec; 28(6):319-24. PubMed ID: 11465137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can 3'-Deoxy-3'-((18)F) Fluorothymidine Out Perform 2-Deoxy-2-((18)F) Fluoro-D-Glucose Positron Emission Tomography/Computed Tomography in the Diagnosis of Cervical Lymphadenopathy in Patients With Oral/Head and Neck Cancer?
    Schaefferkoetter JD; Carlson ER; Heidel RE
    J Oral Maxillofac Surg; 2015 Jul; 73(7):1420-8. PubMed ID: 25869746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Positron emission tomography/computerized tomography (PET/CT) scanning for preoperative staging of patients with oral/head and neck cancer.
    Nahmias C; Carlson ER; Duncan LD; Blodgett TM; Kennedy J; Long MJ; Carr C; Hubner KF; Townsend DW
    J Oral Maxillofac Surg; 2007 Dec; 65(12):2524-35. PubMed ID: 18022480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 18F-FDG PET and CT/MRI in oral cavity squamous cell carcinoma: a prospective study of 124 patients with histologic correlation.
    Ng SH; Yen TC; Liao CT; Chang JT; Chan SC; Ko SF; Wang HM; Wong HF
    J Nucl Med; 2005 Jul; 46(7):1136-43. PubMed ID: 16000282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of FDG-PET/CT imaging on nodal staging for head-and-neck squamous cell carcinoma.
    Murakami R; Uozumi H; Hirai T; Nishimura R; Shiraishi S; Ota K; Murakami D; Tomiguchi S; Oya N; Katsuragawa S; Yamashita Y
    Int J Radiat Oncol Biol Phys; 2007 Jun; 68(2):377-82. PubMed ID: 17321066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 18F fluorodeoxyglucose PET/CT in head and neck squamous cell carcinoma with negative neck palpation findings: a prospective study.
    Roh JL; Park JP; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
    Radiology; 2014 Apr; 271(1):153-61. PubMed ID: 24475791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FDG-PET/CT imaging for preradiotherapy staging of head-and-neck squamous cell carcinoma.
    Schwartz DL; Ford E; Rajendran J; Yueh B; Coltrera MD; Virgin J; Anzai Y; Haynor D; Lewellyn B; Mattes D; Meyer J; Phillips M; Leblanc M; Kinahan P; Krohn K; Eary J; Laramore GE
    Int J Radiat Oncol Biol Phys; 2005 Jan; 61(1):129-36. PubMed ID: 15629603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utility of FDG PET in patients with squamous cell carcinomas of the oral cavity.
    Kim SY; Roh JL; Kim JS; Ryu CH; Lee JH; Cho KJ; Choi SH; Nam SY
    Eur J Surg Oncol; 2008 Feb; 34(2):208-15. PubMed ID: 17482789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical values of (18) F-FDG PET/CT in oral cavity cancer with dental artifacts on CT or MRI.
    Hong HR; Jin S; Koo HJ; Roh JL; Kim JS; Cho KJ; Choi SH; Nam SY; Kim SY
    J Surg Oncol; 2014 Nov; 110(6):696-701. PubMed ID: 24995957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Performance of 18F-FDG PET/contrast-enhanced CT in the staging of squamous cell carcinoma of the oral cavity and oropharynx.
    Krabbe CA; Balink H; Roodenburg JL; Dol J; de Visscher JG
    Int J Oral Maxillofac Surg; 2011 Nov; 40(11):1263-70. PubMed ID: 21824748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-small cell lung cancer: prospective comparison of integrated FDG PET/CT and CT alone for preoperative staging.
    Shim SS; Lee KS; Kim BT; Chung MJ; Lee EJ; Han J; Choi JY; Kwon OJ; Shim YM; Kim S
    Radiology; 2005 Sep; 236(3):1011-9. PubMed ID: 16014441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of whole-body FDG-PET in preoperative assessment of tumor staging in oral cancers.
    Nakasone Y; Inoue T; Oriuchi N; Takeuchi K; Negishi A; Endo K; Mogi K
    Ann Nucl Med; 2001 Dec; 15(6):505-12. PubMed ID: 11831398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preoperative intrathoracic lymph node staging in patients with non-small-cell lung cancer: accuracy of integrated positron emission tomography and computed tomography.
    Billé A; Pelosi E; Skanjeti A; Arena V; Errico L; Borasio P; Mancini M; Ardissone F
    Eur J Cardiothorac Surg; 2009 Sep; 36(3):440-5. PubMed ID: 19464906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Staging of untreated squamous cell carcinoma of buccal mucosa with 18F-FDG PET: comparison with head and neck CT/MRI and histopathology.
    Yen TC; Chang JT; Ng SH; Chang YC; Chan SC; Wang HM; See LC; Chen TM; Kang CJ; Wu YF; Lin KJ; Liao CT
    J Nucl Med; 2005 May; 46(5):775-81. PubMed ID: 15872350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Whole Body MRI in the Staging of Esophageal Cancer--A Prospective Comparison with Whole Body 18F-FDG PET-CT.
    Malik V; Harmon M; Johnston C; Fagan AJ; Claxton Z; Ravi N; O'Toole D; Muldoon C; Keogan M; Reynolds JV; Meaney JF
    Dig Surg; 2015; 32(5):397-408. PubMed ID: 26315570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 18F-FDG PET/CT for detecting nodal metastases in patients with oral cancer staged N0 by clinical examination and CT/MRI.
    Schöder H; Carlson DL; Kraus DH; Stambuk HE; Gönen M; Erdi YE; Yeung HW; Huvos AG; Shah JP; Larson SM; Wong RJ
    J Nucl Med; 2006 May; 47(5):755-62. PubMed ID: 16644744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of the introduction of integrated PET-CT into the preoperative staging pathway of patients with potentially operable oesophageal carcinoma.
    Salahudeen HM; Balan A; Naik K; Mirsadraee S; Scarsbrook AF
    Clin Radiol; 2008 Jul; 63(7):765-73. PubMed ID: 18555034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.